Literature DB >> 809531

Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations.

J Siegel, A P Osmand, M F Wilson, H Gewurz.   

Abstract

Cationic homopolymers of poly-L-lysine were found to activate complement (C) via C-reactive protein (CRP) and deplete C3 and C5 as well as early-acting C components. Maximum C consumption was obtained with polymers of 2,000-8,000 daltons; polymers of 1,700, 11,000, and 23,000 daltons were intermediate in reactivity, while L-lysine, lysyl-L-lysine, tetra-L-lysine, and polymers of 70,000-400,000 daltons lacked significant C-consuming activity. Naturally occurring polycations which consumed C in the presence of CRP included myelin basic proteins, cationic proteins of rabbit leukocytes, and both lysine- and arginine-rich histones; poly-L-arginine polymers of 17,000 but not 65,000 daltons also were C-consuming. Polycations without such reactivity included poly-L-orithine (5,000 and 165,000 daltons), egg white and human lysozymes, and Polybrene. The polycations which failed to induce C consumption via CRP, inhibited its consumption by both active polycations and by C-polysaccharide (CPS). The relative inhibitory capacity of phosphorylcholine and polycations in CPS- and polycations-CRP systems was consistent with the concept that phosphate esters and polycations react at the same or an overlapping combining site. The ability of certain polycations to activate C via CRP increases the potential for initiation of host reactions via C. The capacity of other polycations to inhibit C activation via CRP introduces a potential for physiologic or pharmacologic manipulation. These considerations would seem to expand the potential role of CRP in the initiation and modulation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809531      PMCID: PMC2189923          DOI: 10.1084/jem.142.3.709

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

2.  Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.

Authors:  J E Volanakis; M H Kaplan
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

3.  Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria.

Authors:  C O Kindmark
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

4.  Activation of rat mast cells by low molecular weight stimuli.

Authors:  D C Morrison; J F Roser; P M Henson; C G Cochrane
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.

Authors:  B F Driscoll; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

6.  Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.

Authors:  J E Volanakis; M H Kaplan
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

7.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

8.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS.

Authors:  W S Tillett; T Francis
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

9.  Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

Authors:  R F Mortensen; A P Osmand; H Gewurz
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

10.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  A comparison of the acute-phase response in middle aged and elderly patients.

Authors:  J Woo; M Arumanayagam; D MacDonald; K S Woo
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

3.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

8.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.

Authors:  I Kushner; M L Broder; D Karp
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Lymphocytes binding C-reactive protein during acute rheumatic fever.

Authors:  R C Williams; K A Kilpatrick; M Kassaby; Z H Abdin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Authors:  G J Becker; M Waldburger; G R Hughes; M B Pepys
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.